Foscarneto Sódico Kabi

Foscarnet Sodium Hexahydrate is an antiviral medication used for intravenous administration. It is primarily indicated for the treatment of CMV retinitis in patients with AIDS. This medication is manufactured by Fresenius Kabi Pharma Portugal, Lda.

Foscarnet Sodium Hexahydrate is used to treat cytomegalovirus (CMV) retinitis in patients with AIDS. It works by inhibiting the replication of the virus, helping to manage the progression of the infection. This medication is administered intravenously and is typically used in clinical settings under medical supervision.

Common effects of Foscarnet Sodium Hexahydrate may include nausea, vomiting, and changes in kidney function. Some patients may also experience electrolyte imbalances or changes in blood pressure. It is important to monitor for any adverse reactions and consult a healthcare provider if significant side effects occur.

Foscarnet Sodium Hexahydrate should be handled with care, ensuring proper sterile techniques during administration. Patients with pre-existing kidney conditions should be monitored closely, as the medication can affect kidney function. Regular blood tests may be recommended to check for any changes in electrolyte levels or kidney function.

Foscarnet Sodium Hexahydrate may interact with other medications, particularly those that affect kidney function or electrolyte balance. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain over-the-counter drugs may also affect the efficacy or safety of this medication.